CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
首页Home / 产品查询Product Search / 按品种找对照品By drug substance / 苯甲酸利扎曲普坦Rizatriptan Benzoate
Rizatriptan Benzoate

苯甲酸利扎曲普坦 杂质对照品Rizatriptan Benzoate Impurities

EP23 个杂质条目23 impurity entries

本页汇总 苯甲酸利扎曲普坦 的 23 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 23 impurity reference standards of Rizatriptan Benzoate with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 苯甲酸利扎曲普坦(Rizatriptan Benzoate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of UV spectrophotometric method to study stress degradation behaviour of rizatriptan benzoate
    Guang pu xue yu guang pu fen xi = Guang pu · 2015 · Amolkumar K et al.  ·  PMID 25993836
  2. 杂质研究Impurity studiesIdentification, isolation and characterization of process-related impurities in Rizatriptan benzoate
    Journal of pharmaceutical and biomedical analysis · 2009 · Raj TJ et al.  ·  PMID 19056198  ·  DOI
  3. 杂质研究Impurity studiesDevelopment and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate
    Journal of pharmaceutical and biomedical analysis · 2006 · Mallikarjuna Rao B et al.  ·  PMID 16563688  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and validation of reversed-phase high-performance liquid chromatography method for estimation of rizatriptan benzoate in oral strip formulations
    Journal of basic and clinical pharmacy · 2014 · Bhagawati ST et al.  ·  PMID 25538465  ·  DOI
  5. 分析方法Analytical MethodsSimultaneous voltammetric determination of rizatriptan and acetaminophen using a carbon paste electrode modified with NiFe(2)O(4) nanoparticles
    Mikrochimica acta · 2020 · Nouri M et al.  ·  PMID 32383071  ·  DOI

苯甲酸利扎曲普坦 —— 原料药与杂质对照品Rizatriptan Benzoate — drug substance & impurities

共 24 个条目(含原料药本体)24 items incl. the drug substance
Rizatriptan Benzoate structure
EP原料药 APIAPI
苯甲酸利扎曲普坦Rizatriptan Benzoate
Rizatriptan Benzoate
CAS No.145202-66-0
Chemical FormulaC15H19N5·C7H6O2
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 1 (Rizatriptan Benzoate EP Impurity A) structure
EPA
苯甲酸利扎曲普坦杂质1 (苯甲酸利扎曲普坦EP杂质A)Rizatriptan Benzoate Impurity 1 (Rizatriptan Benzoate EP Impurity A)
Rizatriptan Benzoate Impurity 1 (Rizatriptan Benzoate EP Impurity A)
CAS No.887001-08-3
Chemical FormulaC28H35N7
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 3 Benzoate Salt-d6 (Rizatriptan Benzoate EP Impurity C Benzoate Salt-d6) structure
EPC
苯甲酸利扎曲普坦杂质3 苯甲酸盐-d6 (苯甲酸利扎曲普坦EP杂质C 苯甲酸盐-d6)Rizatriptan Benzoate Impurity 3 Benzoate Salt-d6 (Rizatriptan Benzoate EP Impurity C Benzoate Salt-d6)
Rizatriptan Benzoate Impurity 3 Benzoate Salt-d6 (Rizatriptan Benzoate EP Impurity C Benzoate Salt-d6)
CAS No.1216984-85-8
Chemical FormulaC15H13D6N5·C7H6O2
Purity>95%询价On request
Rizatriptan Benzoate Impurity 3 (Rizatriptan Benzoate EP Impurity C) structure
EPC
苯甲酸利扎曲普坦杂质3 (苯甲酸利扎曲普坦EP杂质C)Rizatriptan Benzoate Impurity 3 (Rizatriptan Benzoate EP Impurity C)
Rizatriptan Benzoate Impurity 3 (Rizatriptan Benzoate EP Impurity C)
CAS No.208941-96-2
Chemical FormulaC15H19N5
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 6 (Rizatriptan Benzoate EP Impurity F) structure
EPF
苯甲酸利扎曲普坦杂质6 (苯甲酸利扎曲普坦EP杂质F)Rizatriptan Benzoate Impurity 6 (Rizatriptan Benzoate EP Impurity F)
Rizatriptan Benzoate Impurity 6 (Rizatriptan Benzoate EP Impurity F)
CAS No.160194-39-8
Chemical FormulaC13H14N4O
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 7 (Rizatriptan Benzoate EP Impurity G) structure
EPG
苯甲酸利扎曲普坦杂质7 (苯甲酸利扎曲普坦EP杂质G)Rizatriptan Benzoate Impurity 7 (Rizatriptan Benzoate EP Impurity G)
Rizatriptan Benzoate Impurity 7 (Rizatriptan Benzoate EP Impurity G)
CAS No.1000673-59-5
Chemical FormulaC13H13ClN4
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 8 (Rizatriptan Benzoate EP Impurity H) structure
EPH
苯甲酸利扎曲普坦杂质8 (苯甲酸利扎曲普坦EP杂质H)Rizatriptan Benzoate Impurity 8 (Rizatriptan Benzoate EP Impurity H)
Rizatriptan Benzoate Impurity 8 (Rizatriptan Benzoate EP Impurity H)
CAS No.260435-42-5
Chemical FormulaC15H19N5O
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 9 (Rizatriptan Benzoate EP Impurity I) structure
EPI
苯甲酸利扎曲普坦杂质9 (苯甲酸利扎曲普坦EP杂质I)Rizatriptan Benzoate Impurity 9 (Rizatriptan Benzoate EP Impurity I)
Rizatriptan Benzoate Impurity 9 (Rizatriptan Benzoate EP Impurity I)
CAS No.144034-84-4
Chemical FormulaC14H17N5
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 9-d3 (Rizatriptan Benzoate EP Impurity I-d3) structure
EPI-D3
苯甲酸利扎曲普坦杂质9-d3 (苯甲酸利扎曲普坦EP杂质I-d3)Rizatriptan Benzoate Impurity 9-d3 (Rizatriptan Benzoate EP Impurity I-d3)
Rizatriptan Benzoate Impurity 9-d3 (Rizatriptan Benzoate EP Impurity I-d3)
CAS No.1215678-02-6
Chemical FormulaC14H14D3N5
Purity>95%询价On request
Rizatriptan Benzoate Impurity 3-d6 (Rizatriptan Benzoate EP Impurity C-d6) structure
EPC-D6
苯甲酸利扎曲普坦杂质3-d6 (苯甲酸利扎曲普坦EP杂质C-d6)Rizatriptan Benzoate Impurity 3-d6 (Rizatriptan Benzoate EP Impurity C-d6)
Rizatriptan Benzoate Impurity 3-d6 (Rizatriptan Benzoate EP Impurity C-d6)
CAS No.1329834-30-1
Chemical FormulaC15H13D6N5
Purity>95%询价On request
Rizatriptan Benzoate Impurity 8-d6 (Rizatriptan Benzoate EP Impurity H-d6) structure
EPH-D6
苯甲酸利扎曲普坦杂质8-d6 (苯甲酸利扎曲普坦EP杂质H-d6)Rizatriptan Benzoate Impurity 8-d6 (Rizatriptan Benzoate EP Impurity H-d6)
Rizatriptan Benzoate Impurity 8-d6 (Rizatriptan Benzoate EP Impurity H-d6)
CAS No.1261392-57-7
Chemical FormulaC15H13D6N5O
Purity>95%询价On request
Rizatriptan structure
—
利扎曲普坦Rizatriptan
Rizatriptan
CAS No.144034-80-0
Chemical FormulaC15H19N5
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Dimer Impurity 3 structure
3
利扎曲普坦二聚体杂质3Rizatriptan Dimer Impurity 3
Rizatriptan Dimer Impurity 3
CAS No.1016900-25-6
Chemical FormulaC35H41N7O2
Purity>95%现货In stock
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 10 structure
10
苯甲酸利扎曲普坦杂质10Rizatriptan Benzoate Impurity 10
Rizatriptan Benzoate Impurity 10
CAS No.174610-17-4
Chemical FormulaC15H19N5
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 11 structure
11
苯甲酸利扎曲普坦杂质11Rizatriptan Benzoate Impurity 11
Rizatriptan Benzoate Impurity 11
CAS No.6085-94-5
Chemical FormulaC9H9N3
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 12 structure
12
苯甲酸利扎曲普坦杂质12Rizatriptan Benzoate Impurity 12
Rizatriptan Benzoate Impurity 12
CAS No.119192-11-9
Chemical FormulaC9H9N3O
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan impurity 19 Benzoic acid structure
19
利扎曲普坦杂质19 苯甲酸Rizatriptan impurity 19 Benzoic acid
Rizatriptan impurity 19 Benzoic acid
CAS No.1391062-44-4
Chemical FormulaC16H21N5O
Purity>95%现货In stock
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 20 structure
20
苯甲酸利扎曲普坦杂质20Rizatriptan Benzoate Impurity 20
Rizatriptan Benzoate Impurity 20
CAS No.144035-41-6
Chemical FormulaC21H23N5
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 21 structure
21
苯甲酸利扎曲普坦杂质21Rizatriptan Benzoate Impurity 21
Rizatriptan Benzoate Impurity 21
CAS No.144035-40-5
Chemical FormulaC20H21N5
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 22 structure
22
苯甲酸利扎曲普坦杂质22Rizatriptan Benzoate Impurity 22
Rizatriptan Benzoate Impurity 22
CAS No.1135479-41-2
Chemical FormulaC36H49N11
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 23 structure
23
苯甲酸利扎曲普坦杂质23Rizatriptan Benzoate Impurity 23
Rizatriptan Benzoate Impurity 23
CAS No.1030849-63-8
Chemical FormulaC16H22N5+·Cl-
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 24 structure
24
苯甲酸利扎曲普坦杂质24Rizatriptan Benzoate Impurity 24
Rizatriptan Benzoate Impurity 24
CAS No.1391062-45-5
Chemical FormulaC16H21N5O·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 25 structure
25
苯甲酸利扎曲普坦杂质25Rizatriptan Benzoate Impurity 25
Rizatriptan Benzoate Impurity 25
CAS No.1135479-44-5
Chemical FormulaC36H49N11
Purity>95%询价On request
10mg25mg50mg100mg
Rizatriptan Benzoate Impurity 26 structure
26
苯甲酸利扎曲普坦杂质26Rizatriptan Benzoate Impurity 26
Rizatriptan Benzoate Impurity 26
CAS No.1016900-28-9
Chemical FormulaC13H15N5·HCl
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

苯甲酸利扎曲普坦 —— 研究文献与合成路线Rizatriptan Benzoate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 苯甲酸利扎曲普坦 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Rizatriptan Benzoate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development and validation of a specific stability indicating high performance liquid chromatographic method for rizatriptan benzoate
    Mallikarjuna Rao B, Sangaraju S, Srinivasu MK, et al. · Journal of pharmaceutical and biomedical analysis · 2006 · 被引 16cited 16
  2. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate
    Raj TJ, Bharathi Ch, Kumar MS, et al. · Journal of pharmaceutical and biomedical analysis · 2009 · 被引 5cited 5
  3. Development and validation of UV spectrophotometric method to study stress degradation behaviour of rizatriptan benzoate
    Amolkumar K, Ashok T, Kiran J · Guang pu xue yu guang pu fen xi = Guang pu · 2015

合成与制备工艺专利Synthesis & process patents

  1. Method for preparing rizatriptan benzoate
    YUELING SHI, WEIFENG TAO, LILONG XIE, YOUBIN FAN, et al. · 公开号 CN101085771CN101085771 · 2007
  2. IMPROVED PROCESS FOR THE PREPARATION OF RIZATRIPTAN BENZOATE
    PULLA REDDY MUDDASANI, SATYASRINIVAS HANUMARA, RADHARANI KAGITHA, VENKAIAH CHOWDARY NANNAPANENI · 公开号 WO2006137083WO2006137083 · 2006
  3. PROCESS FOR THE LARGE SCALE PRODUCTION OF RIZATRIPTAN BENZOATE
    RAY PURNA CHANDRA, BANDARI MOHAN, QADEERUDDIN MOHAMMED, RAMANJANEYULU GORANTLA SEETA · 公开号 WO2007054979WO2007054979 · 2007
  4. PROCESS FOR THE LARGE SCALE PRODUCTION OF RIZATRIPTAN BENZOATE
    RAY PURNA CHANDRA, BANDARI MOHAN, QADEERUDDIN MOHAMMED, RAMANJANEYULU GORANTLA SEETA · 公开号 EP1951713EP1951713 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

苯甲酸利扎曲普坦 杂质谱研究要点Rizatriptan Benzoate — impurity profiling notes

下面这些是拿到 苯甲酸利扎曲普坦 的 24 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 24 impurity entries for Rizatriptan Benzoate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances